Artwork

Contenido proporcionado por Gut Check Project. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Gut Check Project o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

LDN Unlocked: Journey to Wellness with Low Dose Naltrexone

1:38:59
 
Compartir
 

Manage episode 419540582 series 3361220
Contenido proporcionado por Gut Check Project. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Gut Check Project o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

DEEP DIVE into (LDN) Low Dose Naltrexone with Sebastion Denison, RPh, Andy Komuves, RPh, & Joe Bertrand, RPh


Low Dose Naltrexone (LDN) Clearly from the adjectives it’s a “non standard” dosage from what naltrexone was originally intended. But why?

LDN is a method (with EXTENSIVE data) of finding benefits to healing from certain issues that have often left people hopeless.

Weight management, nerve damage, palsy, autoimmune thyroid disorders, cancer, chronic fatigue syndrome, chronic pain,Crohn’s diease, fibromyalgia, PTSD, multiple sclerosis, myalgic encephalomyelitis.

The GCP welcomes three experts and Clinical Compounding Pharmacists to share with you their knowledge and experience in helping people find comfort and happiness again in their lives! Sebastion Denison, RPh, Andy Komuves, RPh, & Joe Bertrand, RPh join Ken & Eric to discuss the hype and evidence around LDN.



REFERENCES

https://a4pc.org/

https://www.pccarx.com/Resources/FindACompounder

https://www.achc.org/compounding-pharmacy/

https://ldnresearchtrust.org/

https://ldnresearchtrust.org/2024_LDN_Guides

https://ldnresearchtrust.org/sites/default/files/2024-02/Dosing-Guide-2024_0.pdf

current dosing recommendations

https://www.jpsmjournal.com/article/S0885-3924%2803%2900139-8/fulltext

Ultra low dose early info

Purdue had Oxycontin and the combination was used clinically and was pursued, then Oxytrex was the trade name-2005 phase 3 trials, by a company Pain Therapeutics-but did not launch or fully launch

TROXYCA® ER is a Pfizer product in 2016 (higher doses)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf

  continue reading

150 episodios

Artwork
iconCompartir
 
Manage episode 419540582 series 3361220
Contenido proporcionado por Gut Check Project. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Gut Check Project o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

DEEP DIVE into (LDN) Low Dose Naltrexone with Sebastion Denison, RPh, Andy Komuves, RPh, & Joe Bertrand, RPh


Low Dose Naltrexone (LDN) Clearly from the adjectives it’s a “non standard” dosage from what naltrexone was originally intended. But why?

LDN is a method (with EXTENSIVE data) of finding benefits to healing from certain issues that have often left people hopeless.

Weight management, nerve damage, palsy, autoimmune thyroid disorders, cancer, chronic fatigue syndrome, chronic pain,Crohn’s diease, fibromyalgia, PTSD, multiple sclerosis, myalgic encephalomyelitis.

The GCP welcomes three experts and Clinical Compounding Pharmacists to share with you their knowledge and experience in helping people find comfort and happiness again in their lives! Sebastion Denison, RPh, Andy Komuves, RPh, & Joe Bertrand, RPh join Ken & Eric to discuss the hype and evidence around LDN.



REFERENCES

https://a4pc.org/

https://www.pccarx.com/Resources/FindACompounder

https://www.achc.org/compounding-pharmacy/

https://ldnresearchtrust.org/

https://ldnresearchtrust.org/2024_LDN_Guides

https://ldnresearchtrust.org/sites/default/files/2024-02/Dosing-Guide-2024_0.pdf

current dosing recommendations

https://www.jpsmjournal.com/article/S0885-3924%2803%2900139-8/fulltext

Ultra low dose early info

Purdue had Oxycontin and the combination was used clinically and was pursued, then Oxytrex was the trade name-2005 phase 3 trials, by a company Pain Therapeutics-but did not launch or fully launch

TROXYCA® ER is a Pfizer product in 2016 (higher doses)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf

  continue reading

150 episodios

Alla avsnitt

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida